anagrelide

Generic: anagrelide

Labeler: ani pharmaceuticals, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name anagrelide
Generic Name anagrelide
Labeler ani pharmaceuticals, inc.
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

anagrelide hydrochloride .5 mg/1

Manufacturer
ANI Pharmaceuticals, Inc.

Identifiers & Regulatory

Product NDC 70954-879
Product ID 70954-879_56b3959d-4b6b-413f-b753-9d4c20c07466
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA076811
Listing Expiration 2026-12-31
Marketing Start 2025-11-06

Pharmacologic Class

Classes
decreased platelet production [pe] phosphodiesterase 3 inhibitors [moa] platelet-reducing agent [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 70954879
Hyphenated Format 70954-879

Supplemental Identifiers

RxCUI
597850 597852
UNII
YTM763Y5C8

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name anagrelide (source: ndc)
Generic Name anagrelide (source: ndc)
Application Number ANDA076811 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • .5 mg/1
source: ndc
Packaging
  • 100 CAPSULE in 1 BOTTLE (70954-879-10)
source: ndc

Packages (1)

70954-879-10 100 CAPSULE in 1 BOTTLE (70954-879-10)

Ingredients (1)

anagrelide hydrochloride (.5 mg/1)

Linked Drug Pages (1)

Anagrelide ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "56b3959d-4b6b-413f-b753-9d4c20c07466", "openfda": {"unii": ["YTM763Y5C8"], "rxcui": ["597850", "597852"], "spl_set_id": ["56b3959d-4b6b-413f-b753-9d4c20c07466"], "manufacturer_name": ["ANI Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE (70954-879-10)", "package_ndc": "70954-879-10", "marketing_start_date": "20251106"}], "brand_name": "Anagrelide", "product_id": "70954-879_56b3959d-4b6b-413f-b753-9d4c20c07466", "dosage_form": "CAPSULE", "pharm_class": ["Decreased Platelet Production [PE]", "Phosphodiesterase 3 Inhibitors [MoA]", "Platelet-reducing Agent [EPC]"], "product_ndc": "70954-879", "generic_name": "Anagrelide", "labeler_name": "ANI Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Anagrelide", "active_ingredients": [{"name": "ANAGRELIDE HYDROCHLORIDE", "strength": ".5 mg/1"}], "application_number": "ANDA076811", "marketing_category": "ANDA", "marketing_start_date": "20251106", "listing_expiration_date": "20261231"}